A Phase 3B study of lenalidomide plus rituximab maintenance therapy followed by lenalidomide Single agent maintenance versus rituxumab maintenance in subjects with relapsed/refractory follicular, marginal zone or mantle cell lymphoma - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 3B study of lenalidomide plus rituximab maintenance therapy followed by lenalidomide Single agent maintenance versus rituxumab maintenance in subjects with relapsed/refractory follicular, marginal zone or mantle cell lymphoma

Type of Cancer
Lymphoma
Locations
East Brunswick
Freehold
Howell
Sparta
Sponsor
Celgene
Protocol Number
CC-5013-NHL-008 MAGNIFY
Cancer Diagnosis
To Learn More Call
201-510-0910